Serum Developmental Endothelial Locus-1 is Associated with Severity of Sepsis in Animals and Humans
Authors
Affiliations
Disruption of the endothelial glycocalyx has a prominent role in the pathophysiology of sepsis. Developmental endothelial locus-1 (Del-1) is an endothelial-derived anti-inflammatory factor. We hypothesized that degradation of the endothelial glycocalyx during sepsis may increase serum Del-1. A mouse model of sepsis was created using cecal ligation and puncture. In septic mice, the endothelial glycocalyx was nearly completely degraded, with less formation of Del-1 in the endothelium and extracellular matrix than in control mice. Serum Del-1 levels were significantly increased in the septic mice with increasing severity of sepsis. Serum Del-1 levels were also measured in 84 patients with sepsis and septic shock and in 20 control subjects. The median serum Del-1 level in patients with sepsis was significantly higher than that in healthy controls. The high Del-1 group had higher illness severity scores and contained more patients with organ dysfunction than the low Del-1 group. The 90-day mortality rate was significantly higher in the high Del-1 group than in the low Del-1 group. Multivariate analysis indicated a tendency for a high serum Del-1 level to be associated with a higher mortality risk. Increased serum Del-1 may be a novel diagnostic biomarker of sepsis and an indicator of disease severity.
Plasma EphA2 level is a superior biomarker to Del-1 for sepsis diagnosis and prognosis.
Lee E, Shin M, Kwak S, Choi J, Leem A, Lee S Front Med (Lausanne). 2025; 12:1505882.
PMID: 39926431 PMC: 11802418. DOI: 10.3389/fmed.2025.1505882.
An IL-10/DEL-1 axis supports granulopoiesis and survival from sepsis in early life.
Vergadi E, Kolliniati O, Lapi I, Ieronymaki E, Lyroni K, Alexaki V Nat Commun. 2024; 15(1):680.
PMID: 38263289 PMC: 10805706. DOI: 10.1038/s41467-023-44178-y.
Romanidou G, Konstantinidis T, Natsi A, Kantartzi K, Panopoulou M, Kontomanolis E Int J Mol Sci. 2023; 24(14).
PMID: 37511523 PMC: 10380227. DOI: 10.3390/ijms241411762.
Zhao M, Zheng Z, Li C, Wan J, Wang M Front Immunol. 2022; 13:1053175.
PMID: 36518760 PMC: 9742254. DOI: 10.3389/fimmu.2022.1053175.
Joo D, Lee K, Lee C, Woo J, Kim J, Park S Respir Res. 2021; 22(1):297.
PMID: 34801026 PMC: 8605521. DOI: 10.1186/s12931-021-01878-7.